Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Equity / Common Stock, $0.01 par value per share
-
Shares outstanding
-
209,618,986
-
Total 13F shares
-
68,664,954
-
Share change
-
+1,686,738
-
Total reported value
-
$381,777,979
-
Put/Call ratio
-
32%
-
Price per share
-
$5.56
-
Number of holders
-
109
-
Value change
-
+$5,091,371
-
Number of buys
-
57
-
Number of sells
-
43
Institutional Holders of BIOCRYST PHARMACEUTICALS INC - Common Stock, $0.01 par value per share (BCRX) as of Q2 2017
As of 30 Jun 2017,
BIOCRYST PHARMACEUTICALS INC - Common Stock, $0.01 par value per share (BCRX) was held by
109 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
68,664,954 shares.
The largest 10 holders included
BAKER BROS. ADVISORS LP, BlackRock Inc., VANGUARD GROUP INC, RA CAPITAL MANAGEMENT, LLC, STATE STREET CORP, DEERFIELD MANAGEMENT CO, MILLENNIUM MANAGEMENT LLC, RTW INVESTMENTS, LP, FMR LLC, and VHCP Management II, LLC.
This page lists
111
institutional shareholders reporting positions in this security
for the Q2 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.